166 related articles for article (PubMed ID: 19180802)
21. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
22. Naturally occurring human antibodies to the F(ab')2 portion of IgG.
Nasu H; Chia DS; Knutson DW; Barnett EV
Clin Exp Immunol; 1980 Nov; 42(2):378-86. PubMed ID: 6970643
[TBL] [Abstract][Full Text] [Related]
23. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
Dunn DL; Mach PA; Condie RM; Cerra FB
Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
[TBL] [Abstract][Full Text] [Related]
24. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
Peräalä-Heape M; Vihko P; Vihko R
Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
[TBL] [Abstract][Full Text] [Related]
25. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
26. The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab].
Sedlacek HH; Gronski P; Hofstaetter T; Kanzy EJ; Schorlemmer HU; Seiler FR
Klin Wochenschr; 1983 Aug; 61(15):723-36. PubMed ID: 6194337
[TBL] [Abstract][Full Text] [Related]
27. Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.
Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Tsang-A-Sjoe MW; Bultink IE; Voskuyl AE; Bentlage AE; Vidarsson G; Wolbink G; Rispens T
J Immunol; 2017 Jan; 198(1):82-93. PubMed ID: 27864476
[TBL] [Abstract][Full Text] [Related]
28. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
[TBL] [Abstract][Full Text] [Related]
29. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom.
León G; Stiles B; Alape A; Rojas G; Gutiérrez JM
Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678
[TBL] [Abstract][Full Text] [Related]
30. Shared V-region antigens and cross-reacting specificities of human IgG anti-F(ab')2 and anti-DNA antibodies.
Williams RC; Malone CC; Silvestris F
Clin Immunol Immunopathol; 1996 Aug; 80(2):194-203. PubMed ID: 8764565
[TBL] [Abstract][Full Text] [Related]
31. Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes.
van Schaijk FG; Boerman OC; Soede AC; McBride WJ; Goldenberg DM; Corstens FH; Oosterwijk E
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1089-95. PubMed ID: 15902440
[TBL] [Abstract][Full Text] [Related]
32. Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo.
Peeters PA; Oussoren C; Eling WM; Crommelin DJ
Biochim Biophys Acta; 1988 Aug; 943(2):137-47. PubMed ID: 3401475
[TBL] [Abstract][Full Text] [Related]
33. Human IgG anti-F(ab')2 antibodies possess rheumatoid factor activity.
Hunt Gerardo S; Persselin JE; Stevens RH
Clin Exp Immunol; 1990 Aug; 81(2):293-300. PubMed ID: 1696866
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.
Smith TW; Lloyd BL; Spicer N; Haber E
Clin Exp Immunol; 1979 Jun; 36(3):384-96. PubMed ID: 114346
[TBL] [Abstract][Full Text] [Related]
35. Anti-F(ab')2 antibody in HIV type 1 infection: relationship to hypergammaglobulinemia and to antibody specific to the V3 loop region of glycoprotein 120.
Morrison SA; Pearson SL; Steigbigel RT
AIDS Res Hum Retroviruses; 1998 Apr; 14(6):491-8. PubMed ID: 9566551
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab')2 and Fab after intravenous administration in the rat.
Bazin-Redureau MI; Renard CB; Scherrmann JM
J Pharm Pharmacol; 1997 Mar; 49(3):277-81. PubMed ID: 9231345
[TBL] [Abstract][Full Text] [Related]
37. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of 125I-labelled Walterinnesia aegyptia venom and its distribution of the venom and its toxin versus slow absorption and distribution of IGG, F(AB')2 and F(AB) of the antivenin.
Ismail M; Abd-Elsalam MA; Al-Ahaidib MS
Toxicon; 1998 Jan; 36(1):93-114. PubMed ID: 9604285
[TBL] [Abstract][Full Text] [Related]
39. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
Olds LC; Miller JJ
Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
[TBL] [Abstract][Full Text] [Related]
40. IgG anti-F(ab')2 antibodies from SLE patients react with immunodominant residues in kappa CDRs, but show reduced C kappa region reactivity.
Williams RC; Malone CC; Roemer JH; Silvestris F; Solomon A
Clin Immunol Immunopathol; 1995 Dec; 77(3):366-73. PubMed ID: 7586748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
